GFAP and Alzheimer disease: Immunohistochemistry for anti-Aß, anti-APP, anti-GFAP and anti-Iba1 showed that there were no detectable AD-like lesions observed in Ship2Δ/Δ mouse brains at 6–9 months of age (Supplementary Fig. 2).